Ralph D. Sanderson

13.5k total citations · 1 hit paper
128 papers, 11.1k citations indexed

About

Ralph D. Sanderson is a scholar working on Cell Biology, Molecular Biology and Hematology. According to data from OpenAlex, Ralph D. Sanderson has authored 128 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Cell Biology, 79 papers in Molecular Biology and 47 papers in Hematology. Recurrent topics in Ralph D. Sanderson's work include Proteoglycans and glycosaminoglycans research (101 papers), Glycosylation and Glycoproteins Research (54 papers) and Multiple Myeloma Research and Treatments (44 papers). Ralph D. Sanderson is often cited by papers focused on Proteoglycans and glycosaminoglycans research (101 papers), Glycosylation and Glycoproteins Research (54 papers) and Multiple Myeloma Research and Treatments (44 papers). Ralph D. Sanderson collaborates with scholars based in United States, Israel and Italy. Ralph D. Sanderson's co-authors include Israël Vlodavsky, Merton Bernfield, Renato V. Iozzo, Anurag Purushothaman, Yang Yang, Vishnu C. Ramani, Neta Ilan, Paul A. Lalor, Thomas J. Kelly and Shyam Bandari and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ralph D. Sanderson

127 papers receiving 11.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

2002 507 citations Fenghuang Zhan, Ralph D. Sanderson et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ralph D. Sanderson United States	64	7.2k	6.0k	2.1k	2.1k	1.8k	128	11.1k
Neta Ilan Israel	53	5.8k 0.8×	6.0k 1.0×	959 0.5×	1.1k 0.5×	1.0k 0.6×	156	8.4k
Margot Zöller Germany	53	8.1k 1.1×	3.9k 0.7×	700 0.3×	3.3k 1.6×	3.1k 1.7×	197	13.2k
Martin Götte Germany	53	6.1k 0.8×	4.8k 0.8×	403 0.2×	2.0k 1.0×	1.6k 0.9×	214	11.2k
Eva A. Turley Canada	53	5.0k 0.7×	5.4k 0.9×	436 0.2×	1.0k 0.5×	1.3k 0.7×	119	9.2k
Alan C. Rapraeger United States	54	6.2k 0.9×	6.2k 1.0×	610 0.3×	1.3k 0.6×	666 0.4×	83	9.2k
Reuven Reich Israel	59	5.4k 0.8×	1.3k 0.2×	993 0.5×	3.4k 1.6×	3.0k 1.7×	202	11.2k
Taina Pihlajaniemi Finland	63	6.9k 1.0×	3.2k 0.5×	635 0.3×	2.3k 1.1×	1.6k 0.9×	247	12.6k
Raija Tammi Finland	56	6.4k 0.9×	6.5k 1.1×	273 0.1×	1.1k 0.5×	2.3k 1.3×	161	11.1k
Suneel Apte United States	64	4.7k 0.7×	1.5k 0.3×	1.8k 0.8×	4.8k 2.3×	2.5k 1.4×	191	11.7k
Kristiina Vuori United States	44	5.5k 0.8×	3.1k 0.5×	408 0.2×	1.4k 0.7×	1.5k 0.8×	81	9.0k

Countries citing papers authored by Ralph D. Sanderson

Since Specialization

Citations

This map shows the geographic impact of Ralph D. Sanderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph D. Sanderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph D. Sanderson more than expected).

Fields of papers citing papers by Ralph D. Sanderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph D. Sanderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph D. Sanderson. The network helps show where Ralph D. Sanderson may publish in the future.

Co-authorship network of co-authors of Ralph D. Sanderson

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph D. Sanderson. A scholar is included among the top collaborators of Ralph D. Sanderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph D. Sanderson. Ralph D. Sanderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Naroditsky, Inna, Sari Feld, Ilanit Boyango, et al.. (2024). Nuclear localization of heparanase 2 (Hpa2) attenuates breast carcinoma growth and metastasis. Cell Death and Disease. 15(3). 232–232. 4 indexed citations

Vlodavsky, Israël, et al.. (2023). Heparanase—A single protein with multiple enzymatic and nonenzymatic functions. PubMed. 1(3). e6–e6. 21 indexed citations

Ostrovsky, Olga, Katia Beider, Hila Magen, et al.. (2023). Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma. Cells. 12(6). 913–913. 2 indexed citations

Richter, Robert P., Lei Zheng, Daniëlle Pretorius, et al.. (2022). Glycocalyx heparan sulfate cleavage promotes endothelial cell angiopoietin-2 expression by impairing shear stress–related AMPK/FoxO1 signaling. JCI Insight. 7(15). 20 indexed citations

Gutter-Kapon, Lilach, Neta Ilan, Tahira Batool, et al.. (2020). Significance of host heparanase in promoting tumor growth and metastasis. Matrix Biology. 93. 25–42. 24 indexed citations

Bhattacharya, Udayan, Lilach Gutter-Kapon, Ilanit Boyango, et al.. (2019). Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth. Cancer Research. 80(1). 57–68. 38 indexed citations

Beauvais, DeannaLee M., Oisun Jung, Yang Yang, Ralph D. Sanderson, & Alan C. Rapraeger. (2016). Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by SynstatinIGF1R Inhibits Tumor Growth. Cancer Research. 76(17). 4981–4993. 57 indexed citations

Purushothaman, Anurag, et al.. (2013). Heparanase Regulates Secretion, Composition, and Function of Tumor Cell-derived Exosomes. Journal of Biological Chemistry. 288(14). 10093–10099. 282 indexed citations

Ramani, Vishnu C., Yongsheng Ren, Annamaria Naggi, et al.. (2011). SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis. Clinical Cancer Research. 17(6). 1382–1393. 209 indexed citations

10.

Yang, Yang, Yongsheng Ren, Vishnu C. Ramani, et al.. (2010). Heparanase Enhances Local and Systemic Osteolysis in Multiple Myeloma by Upregulating the Expression and Secretion of RANKL. Cancer Research. 70(21). 8329–8338. 56 indexed citations

11.

Dai, Yuemeng, Yang Yang, Veronica MacLeod, et al.. (2005). HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor Growth in Vivo. Journal of Biological Chemistry. 280(48). 40066–40073. 122 indexed citations

12.

Reiland, Jane, et al.. (2004). Heparanase Degrades Syndecan-1 and Perlecan Heparan Sulfate. Journal of Biological Chemistry. 279(9). 8047–8055. 115 indexed citations

13.

Langford, J. Kevin, Yang Yang, Thomas Kieber‐Emmons, & Ralph D. Sanderson. (2004). Identification of an Invasion Regulatory Domain within the Core Protein of Syndecan-1. Journal of Biological Chemistry. 280(5). 3467–3473. 41 indexed citations

14.

Kelly, Thomas J., Hua‐Quan Miao, Yang Yang, et al.. (2003). High heparanase activity in multiple myeloma is associated with elevated microvessel density.. PubMed. 63(24). 8749–56. 146 indexed citations

15.

Sanderson, Ralph D., et al.. (2001). Sperm protein 17 is expressed on normal and malignant lymphocytes and promotes heparan sulfate–mediated cell-cell adhesion. Blood. 98(7). 2160–2165. 47 indexed citations

16.

Bayer‐Garner, Ilene B., et al.. (2000). Syndecan-1 Expression Is Decreased With Increasing Aggressiveness of Basal Cell Carcinoma. American Journal of Dermatopathology. 22(2). 119–122. 35 indexed citations

17.

Kiessling, Laura L., et al.. (1996). ABSTRACTS SUBMITTED FOR THE 24TH MEETING OF THE SOCIETY FOR GLYCOBIOLOGY. Glycobiology. 6(7). 717–783. 1 indexed citations

18.

Sanderson, Ralph D., et al.. (1995). Syndecans as Anti-invasive Molecules on the Surface of Tumor Cells.. Trends in Glycoscience and Glycotechnology. 7(38). 513–524. 1 indexed citations

19.

Sanderson, Ralph D., Jeremy E. Turnbull, J T Gallagher, & Arthur D. Lander. (1994). Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior.. Journal of Biological Chemistry. 269(18). 13100–13106. 145 indexed citations

20.

Bernfield, Merton & Ralph D. Sanderson. (1990). Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 327(1239). 171–186. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact